Pulmonary Arterial Hypertension Secondary to Drugs and Toxins. Clinics in chest medicine Ramirez, R. L., Pienkos, S. M., de Jesus Perez, V., Zamanian, R. T. 2021; 42 (1): 19–38

Abstract

Pulmonary arterial hypertension secondary to drugs and toxins is an important subgroup of group 1 pulmonary hypertension associated with significant morbidity and mortality. Many drugs and toxins have emerged as risk factors for pulmonary arterial hypertension, which include anorexigens, illicit agents, and several US Food and Drug Administration-approved therapeutic medications. Drugs and toxins are classified as possible or definite risk factors for pulmonary arterial hypertension. This article reviews agents that have been implicated in the development of pulmonary arterial hypertension, their pathologic mechanisms, and methods to prevent the next deadly outbreak of drug- and toxin-induced pulmonary arterial hypertension.

View details for DOI 10.1016/j.ccm.2020.11.008

View details for PubMedID 33541612